The RECOVERY trial: cardiovascular implications of a large, simple randomized trial in COVID-19
Gespeichert in:
| Veröffentlicht in: | Cardiovascular research 2021-07, Vol.117 (9), p.e110-e113 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e113 |
|---|---|
| container_issue | 9 |
| container_start_page | e110 |
| container_title | Cardiovascular research |
| container_volume | 117 |
| creator | Pessoa-Amorim, Guilherme Mafham, Marion M |
| description | |
| doi_str_mv | 10.1093/cvr/cvab239 |
| format | Article |
| fullrecord | <record><control><sourceid>oup_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8318096</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/cvr/cvab239</oup_id><sourcerecordid>10.1093/cvr/cvab239</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-38e411788cedefd227abfe1cb4f140934ac9eafe2eef5ef88cd32bcffa3a0d0d3</originalsourceid><addsrcrecordid>eNp9kMFLwzAUh4Mobk5P3iUnL1pNmnRrPQgypw4GgzEFT-E1edkiXTvSbqB_vRmbQy8ewiN53_se-RFyztkNZ5m41WsfDuSxyA5Im_eSJBKxTA5JmzGWRl3RFS1yUtcf4ZokPXlMWkKKmPGubBM1nSOdDPrjt8HknTbeQXFHNXjjqjXUelWAp26xLJyGxlVlTStLgYbXGV7TetNB6qE01cJ9odkKqCtpEA4fI56dkiMLRY1nu9ohr0-Daf8lGo2fh_2HUaQlj5tIpCg576WpRoPWxHEPcotc59JyGT4pQWcIFmNEm6ANnBFxrq0FAcwwIzrkfutdrvIFGo1l46FQS-8W4D9VBU797ZRurmbVWqWCpyzrBsHVVqB9Vdce7X6WM7XJWYWc1S7nQF_8Xrdnf4INwOUWqFbLf03f8wCJ6Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The RECOVERY trial: cardiovascular implications of a large, simple randomized trial in COVID-19</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Pessoa-Amorim, Guilherme ; Mafham, Marion M</creator><creatorcontrib>Pessoa-Amorim, Guilherme ; Mafham, Marion M</creatorcontrib><identifier>ISSN: 0008-6363</identifier><identifier>EISSN: 1755-3245</identifier><identifier>DOI: 10.1093/cvr/cvab239</identifier><identifier>PMID: 34320164</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Aged ; Anti-Inflammatory Agents - adverse effects ; Anti-Inflammatory Agents - therapeutic use ; Antiviral Agents - adverse effects ; Antiviral Agents - therapeutic use ; Cardiovascular Diseases - diagnosis ; Cardiovascular Diseases - drug therapy ; Cardiovascular Diseases - mortality ; Cardiovascular Research Onlife ; Cause of Death ; COVID-19 - diagnosis ; COVID-19 - mortality ; COVID-19 Drug Treatment ; Female ; Fibrinolytic Agents - adverse effects ; Fibrinolytic Agents - therapeutic use ; Heart Disease Risk Factors ; Humans ; Male ; Middle Aged ; Research Design ; Risk Assessment ; Time Factors ; Treatment Outcome</subject><ispartof>Cardiovascular research, 2021-07, Vol.117 (9), p.e110-e113</ispartof><rights>Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-38e411788cedefd227abfe1cb4f140934ac9eafe2eef5ef88cd32bcffa3a0d0d3</citedby><cites>FETCH-LOGICAL-c412t-38e411788cedefd227abfe1cb4f140934ac9eafe2eef5ef88cd32bcffa3a0d0d3</cites><orcidid>0000-0002-4050-6191</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,1578,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34320164$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pessoa-Amorim, Guilherme</creatorcontrib><creatorcontrib>Mafham, Marion M</creatorcontrib><title>The RECOVERY trial: cardiovascular implications of a large, simple randomized trial in COVID-19</title><title>Cardiovascular research</title><addtitle>Cardiovasc Res</addtitle><subject>Aged</subject><subject>Anti-Inflammatory Agents - adverse effects</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Antiviral Agents - adverse effects</subject><subject>Antiviral Agents - therapeutic use</subject><subject>Cardiovascular Diseases - diagnosis</subject><subject>Cardiovascular Diseases - drug therapy</subject><subject>Cardiovascular Diseases - mortality</subject><subject>Cardiovascular Research Onlife</subject><subject>Cause of Death</subject><subject>COVID-19 - diagnosis</subject><subject>COVID-19 - mortality</subject><subject>COVID-19 Drug Treatment</subject><subject>Female</subject><subject>Fibrinolytic Agents - adverse effects</subject><subject>Fibrinolytic Agents - therapeutic use</subject><subject>Heart Disease Risk Factors</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Research Design</subject><subject>Risk Assessment</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>0008-6363</issn><issn>1755-3245</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMFLwzAUh4Mobk5P3iUnL1pNmnRrPQgypw4GgzEFT-E1edkiXTvSbqB_vRmbQy8ewiN53_se-RFyztkNZ5m41WsfDuSxyA5Im_eSJBKxTA5JmzGWRl3RFS1yUtcf4ZokPXlMWkKKmPGubBM1nSOdDPrjt8HknTbeQXFHNXjjqjXUelWAp26xLJyGxlVlTStLgYbXGV7TetNB6qE01cJ9odkKqCtpEA4fI56dkiMLRY1nu9ohr0-Daf8lGo2fh_2HUaQlj5tIpCg576WpRoPWxHEPcotc59JyGT4pQWcIFmNEm6ANnBFxrq0FAcwwIzrkfutdrvIFGo1l46FQS-8W4D9VBU797ZRurmbVWqWCpyzrBsHVVqB9Vdce7X6WM7XJWYWc1S7nQF_8Xrdnf4INwOUWqFbLf03f8wCJ6Q</recordid><startdate>20210727</startdate><enddate>20210727</enddate><creator>Pessoa-Amorim, Guilherme</creator><creator>Mafham, Marion M</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-4050-6191</orcidid></search><sort><creationdate>20210727</creationdate><title>The RECOVERY trial: cardiovascular implications of a large, simple randomized trial in COVID-19</title><author>Pessoa-Amorim, Guilherme ; Mafham, Marion M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-38e411788cedefd227abfe1cb4f140934ac9eafe2eef5ef88cd32bcffa3a0d0d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Aged</topic><topic>Anti-Inflammatory Agents - adverse effects</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Antiviral Agents - adverse effects</topic><topic>Antiviral Agents - therapeutic use</topic><topic>Cardiovascular Diseases - diagnosis</topic><topic>Cardiovascular Diseases - drug therapy</topic><topic>Cardiovascular Diseases - mortality</topic><topic>Cardiovascular Research Onlife</topic><topic>Cause of Death</topic><topic>COVID-19 - diagnosis</topic><topic>COVID-19 - mortality</topic><topic>COVID-19 Drug Treatment</topic><topic>Female</topic><topic>Fibrinolytic Agents - adverse effects</topic><topic>Fibrinolytic Agents - therapeutic use</topic><topic>Heart Disease Risk Factors</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Research Design</topic><topic>Risk Assessment</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pessoa-Amorim, Guilherme</creatorcontrib><creatorcontrib>Mafham, Marion M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cardiovascular research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pessoa-Amorim, Guilherme</au><au>Mafham, Marion M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The RECOVERY trial: cardiovascular implications of a large, simple randomized trial in COVID-19</atitle><jtitle>Cardiovascular research</jtitle><addtitle>Cardiovasc Res</addtitle><date>2021-07-27</date><risdate>2021</risdate><volume>117</volume><issue>9</issue><spage>e110</spage><epage>e113</epage><pages>e110-e113</pages><issn>0008-6363</issn><eissn>1755-3245</eissn><cop>England</cop><pub>Oxford University Press</pub><pmid>34320164</pmid><doi>10.1093/cvr/cvab239</doi><orcidid>https://orcid.org/0000-0002-4050-6191</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0008-6363 |
| ispartof | Cardiovascular research, 2021-07, Vol.117 (9), p.e110-e113 |
| issn | 0008-6363 1755-3245 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8318096 |
| source | Oxford University Press Journals All Titles (1996-Current); MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Aged Anti-Inflammatory Agents - adverse effects Anti-Inflammatory Agents - therapeutic use Antiviral Agents - adverse effects Antiviral Agents - therapeutic use Cardiovascular Diseases - diagnosis Cardiovascular Diseases - drug therapy Cardiovascular Diseases - mortality Cardiovascular Research Onlife Cause of Death COVID-19 - diagnosis COVID-19 - mortality COVID-19 Drug Treatment Female Fibrinolytic Agents - adverse effects Fibrinolytic Agents - therapeutic use Heart Disease Risk Factors Humans Male Middle Aged Research Design Risk Assessment Time Factors Treatment Outcome |
| title | The RECOVERY trial: cardiovascular implications of a large, simple randomized trial in COVID-19 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T03%3A56%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20RECOVERY%20trial:%20cardiovascular%20implications%20of%20a%20large,%20simple%20randomized%20trial%20in%20COVID-19&rft.jtitle=Cardiovascular%20research&rft.au=Pessoa-Amorim,%20Guilherme&rft.date=2021-07-27&rft.volume=117&rft.issue=9&rft.spage=e110&rft.epage=e113&rft.pages=e110-e113&rft.issn=0008-6363&rft.eissn=1755-3245&rft_id=info:doi/10.1093/cvr/cvab239&rft_dat=%3Coup_pubme%3E10.1093/cvr/cvab239%3C/oup_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/34320164&rft_oup_id=10.1093/cvr/cvab239&rfr_iscdi=true |